desmopressin / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 38 Diseases   30 Trials   30 Trials   1779 News 
40 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
desmopressin / Generic mfg.
ChiCTR-IPR-15007055: The relationship between treatment for persistent nocturia in men following transurethral prostate surgery by Desmopressin Acetate Sublingual Wafer Oral Disintegration Formulation (Minirin Melt? 60 μg) and improvement of sleep quality

Recruiting
4
120
 
Minirin Melt versus placebo, 60mcg before bed, 4 weeks, respectively
The Chinese University of Hong Kong; Level of the institution：, The Chinese University of Hong Kong
Noctura
 
 
2011-004560-29: Desmopressin melt therapy in nocturnal polyuria patients: pharmacodynamic study Desmopressine Melt therapie bij patiënten met nachtelijke polyurie: farmacodynamische studie

Ongoing
4
50
Europe
Desmopressin, Oral lyophilisate, Minirin Melt 60 µg lyophilisaat voor oraal gebruik
Ghent University Hospital, Ghent University Hospital
Noctural polyuria, Noctural polyuria Nachtelijke polyurie, Body processes [G] - Physiological processes [G07]
 
 
2012-001809-24: A diminished concentrating ability of the kidneys due to lithium prescription: how many and whom is affected?

Ongoing
4
100
Europe
Desmopressine nasal spray 10 mg/ml, flacon 60 doses, SUB21605, Nasal spray, solution, Desmopressine nasal spray 10 mg/ml, flacon 60 doses
Radboud University Nijmegen Medical Centre, Radboud University Nijmegen Medical Centre
lithium-induced urinary concentrating defects (nephrogenic diabetes insipidus), excessive urine production due to a diminished urinary concentrating ability of the kidneys, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
2009-017060-17: STIMULATE study: Statins influence on Minrin upregulation of von Willebrand factor and factor VIII

Ongoing
4
20
Europe
simvastatin, Desmopressine, simvastatine, Minrin, simvastatine, Minrin
Academic Medical Center
Type 1 von Willebrand disease and mild hemophilia A
 
 
2014-005435-14: Combination treatment with DDAVP and factor VIII clotting factor concentrates in patients with mild haemophilia A. Combinatiebehandeling van DDAVP en factor VIII-concentraten in patiënten met milde hemofilie A.

Ongoing
4
60
Europe
Solution for injection/infusion, Powder and solvent for solution for injection, Minrin, Octostim, Advate, Kogenate Bayer, Helixate NexGen, ReFacto AF, Aafact, Octanate, NovoEight
Erasmus University Medical Center, ZonMw, Ferring BV, Erasmus University Medical Centre
Mild hemophilia A patients with a FVIII plasma levels above 0.05 IU/mL. Milde hemofilie A-patiënten, A clotting disorder in which clotting factor VIII is deficient, which can cause bleeding. In this study we will look at patients with the mild form. Een stollingsstoornis waarin het gehalte van stollingsfactor VIII is verlaagd. Hierdoor kunnen bloedingen veroorzaakt worden. In deze studie kijken we naar patiënten met een milde vorm., Diseases [C] - Blood and lymphatic diseases [C15]
 
 
2016-001875-57: Desmopressin and FVIII concentrate combination treatment in non-severe hemophilia A patients undergoing minor interventions Desmopressine en FVIII-concentraat combinatiebehandeling in niet-ernstige hemofilie A-patiënten die een kleine ingreep ondergaan

Ongoing
4
70
Europe
Solution for injection/infusion, Solution for injection, Minrin, Octostim
Erasmus University Medical Center Rotterdam, Erasmus University Medical Center Rotterdam, Innovatiefonds zorgverzekeraars
Hemophilia A Hemofilie A, Hemophilia A, a bleeding disorder caused by clotting fcator VIII deficiency, Diseases [C] - Blood and lymphatic diseases [C15]
 
 
PTNS, NCT04545931: Posterior Tibial Nerve Stimulation Vs Desmopressin In Children With Primary Monosymptomatic Nocturnal Enuresis

Recruiting
4
80
RoW
Posterior tibial nerve stimulation, Urgent PC, Desmopressin Acetate
Cairo University
Primary Monosymptomatic Nocturnal Enuresis
11/20
12/20
DRYCHILD, NCT03389412 / 2017-002169-23: The Effect of Selecting Treatment With Desmopressin or Alarm to Children With Enuresis Based on Home Recordings.

Completed
4
324
Europe, RoW
Desmopressin, Minirin, melt, Conditional alarm
University of Aarhus, University Ghent, First Affiliated Hospital of Zhengzhou University, China, University Clinical Centre in Gdansk, Poland
Enuresis, Nocturnal
01/23
01/23
NCT04420585: Desmopressin for Bedwetting in Children With SCD

Terminated
4
8
US
Desmopressin, DDAVP
Montefiore Medical Center
Nocturnal Enuresis, Anemia, Sickle Cell
06/23
06/23
NCT05945420: Adding Desmopressin to Tamsulosin for Treatment of BPH

Recruiting
4
160
RoW
Desmopressin Acetate, Placebo
Mansoura University
Nocturnal Polyurea in Patients With BPH
01/24
02/24
NCT06255366: Analysis of the Clinical Efficacy of Intravenous Application of Hemostatic Drugs in Improving the Clarity of Vision Under Endoscope, Perioperative Bleeding Volume and Anti-inflammatory Effect of Spinal Endoscopic Lumbar Fusion

Not yet recruiting
4
126
NA
Caroxime sodium sulfonate, Desmopressin, 0.9% Sodium Chloride Injection
Chengdu University of Traditional Chinese Medicine
Lumbar Spondylolisthesis, Arthrosis; Spine
12/24
06/25
NCT06622187: Use of Desmopressin Prior to Graft Kidney Biopsy in Patients with High Risk of Bleeding

Enrolling by invitation
4
96
RoW
Desmopressin (DDAVP), Sodium Chloride
Hospital de Clinicas de Porto Alegre
Bleeding, Transplant, Kidney, Desmopressin, Kidney Biopsy
06/26
06/26
2004-001735-37: AN OPEN LABEL STUDY OF ORAL DESMOPRESSIN IN CHILDREN AGED 5 TO 15 YEARS WITH PRIMARY NOCTURAL ENURESIS

Ongoing
3
110
Europe
MINIRIN, Tablet, MINIRIN
FERRING ARZNEIMITTEL Ges.m.b.h. CEE AUSTRIA
Primary noctural enuresis
 
 
2009-017265-33: Invloed van voeding op farmacokinetiek en -dynamiek van desmopressine tablet in vergelijking met desmopressine MELT-vorm

Ongoing
3
24
Europe
Desmopressine MELT, Desmopressine tablet, Oral lyophilisate, Tablet, Minrin MELT, Desmopressine Ferring
University Hospital Ghent
Kinderen met Monosymptomatische Enuresis Nocturna en nachtelijke polyurie
 
 
2005-005199-33: EFFICACY OF DESMOPRESSINA IN PATIENT WITH ACTIVE BLEEDING AFTER HEART SURGERY.

Ongoing
3
108
Europe
EMOSINT INIETT.10F 20 MCG/ML, EMOSINT INIETT.10F 20 MCG/ML
OSPEDALE S. RAFFAELE
HIGH BLEEDING AFTER HEART SURGERY
 
 
2021-006647-99: Efficacy of Desmopressin in safaty outcomes post kindey biopsy

Not yet recruiting
3
424
Europe
Infusion, Minirin (4 mcg/ml)
Medical University of Bialystok, Agencja Badań Medycznych
Rare and ultra-rare glomerulonephritis, Rare and ultra-rare glomerulonephritis, Not possible to specify
 
 
BRACKETS, NCT06337838: Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery () Pilot Trial

Not yet recruiting
3
100
NA
Desmopressin Injectable Solution, DDAVP, Tranexamic Acid Injectable Product, Cyklokapron, Placebo
Population Health Research Institute
Chronic Kidney Diseases, Acute Kidney Injury, Bleeding, Surgery
01/26
04/26
DASSOH, NCT06020495: Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia

Recruiting
3
260
Europe
DDAVP, Standard hyponatremia treatment
Assistance Publique - Hôpitaux de Paris
Hyponatremia
09/26
11/26
STOP-BLEED, NCT05467033: Safety Outcomes Post Kidney Biopsy - Randomized Clinical Evaluation of Efficacy of Desmopressin

Recruiting
3
424
Europe
Desmopressin, Minirin, intravenous infusion NaCl, 0,9% NaCl
Medical University of Bialystok
Kidney Biopsy
08/26
08/26
ACTRN12609000080224: Desmopressin for the Treatment of Orthostatic Hypotension and Excessive Nighttime Urination in Parkinson’s Disease

Recruiting
2
20
 
John O'Sullivan, Royal Brisbane & Women's Hospital
Nocturia, Parkinson's Disease, Orthostatic Hypotension
 
 
2005-003488-22: Regulation des Antidiuretisches Hormons (ADH) und der antidiuretischen Wirkung unter Glucocorticoid - Therapie

Ongoing
2
12
Europe
Decortin H 10 mg, Decortin H 20 mg, Desmopressinacetat, Decortin H 10 mg, Decortin H 20 mg, Minirin parenteral, Decortin H 10 mg, Decortin H 20 mg, Minirin parenteral
Charité CBF, Endokrinologie
Es geht um keine therapeutische Fragestellung. In dem geplanten Versuch mit gesunden Probanden soll der Mechanismus der Wasser Resorption in der Niere trotz supprimiertem ADH nach Glukokortikoid Behandlung untersucht werden.
 
 
2008-002636-15: Study on the treatment of therapy-resistant enuresis with desmopressin and reboxetine; a randomised, placebo-controlled, double-blinded, cross-over study

Ongoing
2
21
Europe
Edronax, Nocutil, Edronax, Nocutil
Uppsala University Children´s Hospital
Nocturnal enuresis (bedwetting)
 
 
2016-001126-33: A randomised controlled trial to evaluate the feasibility of administering a drug called desmopressin to Intensive Care patients prior to procedures or radiological interventions, for prophylaxis against bleeding.

Ongoing
2
40
Europe
OCTIM Injection, Solution for injection/infusion, OCTIM Injection
NHS Blood and Transplant, NHS Blood and Transplant
Thrombocytopenic patients (platelet count less than or equal to 100x109/L) in Intensive Care and due to undergo an interventional procedure., Patients with a low platelet count, in Intensive Care and due to undergo an interventional procedure., Diseases [C] - Blood and lymphatic diseases [C15]
 
 
NCT04586790: the Effect of Oral Vasopressors for Liberation From IV Vasopressors in Spinal Shock

Recruiting
2
90
RoW
Midodrine Oral Tablet, Minirin oral tablet, Nor-Adrenaline
Ahmed talaat ahmed aly
Spinal Shock
01/21
01/21
NCT06635629: Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome

Recruiting
2
140
US
Desmopressin, Dexamethasone
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Cushing Syndrome
10/28
01/29
ChiCTR-TRC-09000690: A Randomized, Double-blind, Placebo-controlled Study on Treatment of Nocturia with Desmopressin in Women

Completed
N/A
100
 
MINIRIN 0.2 mg tablets containing desmopressin acetate 0.2 mg and excipients q.s. (oral; 1 dose per night for 3 weeks) Patients will experience 1-week screening period and 3-week double-blind period ;Placebo (oral; 1 dose per night for 3 weeks)
N.A.; Level of the institution：, Department of Obstetrics & Gynaecology
Nocturia
 
 
ChiCTR1900022678: Desmopressin acetate decreases blood loss in patients with massive hemorrhage undergoing gastrointestinal surgery

Completed
N/A
150
 
desmopressin 0.3 ug/kg,30 min, once a day after the surgery. ;intravenously administered with 50 ml saline for 30 min once a day.
he Sixth Affiliated Hospital of Sun Yat-Sen University; the Sixth Affiliated Hospital of Sun Yat-Sen University, hybio pharmcceutical Co.Ltd
critical care ill
 
 
NCT06185361: Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.

Active, not recruiting
N/A
60
RoW
Fluoxetine 20 MG, Desmopressin
Fayoum University Hospital
Nocturnal Enuresis, Enuresis, Enuresis, Nocturnal
03/24
03/24
GIDEHAC, NCT06020456: Genetic Factors of the Desmopressin Response in Carriers of Hemophilia A

Completed
N/A
361
Europe
Desmopressin
Groupe Maladies hémorragiques de Bretagne
Carrier of Hemophilia A, Desmopressin, Factor VIII Deficiency
01/23
04/23
NCT05507476: Nasal Desmopressin Versus Topical Epinephrine in Endonasal Dacryocystorhinostomy

Completed
N/A
52
RoW
Desmopressin Acetate Nasal, 10 μg/0.1 ml per spray, Minirin 10 μg/0.1 ml per spray, Epinephrine topical 1:100,000 Nasal Packs, Adrenaline 1 mg / 1ml
Zagazig University
Anesthesia
06/23
06/23
NCT05617664: Mirabegron 25 mg for Treatment of Primary Nocturnal Enuresis

Recruiting
N/A
150
RoW
desmopressin 120 mcg oral tablets, Mirabegron 25 MG Oral Tablet, Extended Release, behavioral therapy alone
Benha University
Nocturnal Enuresis
09/23
10/23
NCT05399173: Effect of Laser Acupuncture for Treating Monosymptomatic Nocturnal Enuresis in Adolescent Females

Recruiting
N/A
60
RoW
infrared (gallium aluminum arsenide laser), medical treatment(desmopressin acetate)
Cairo University
Non-Specific Urethritis
09/23
09/23
NOC01, NCT04329975: Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)

Completed
N/A
1087
Japan
Desmopressin, MINIRINMELT
Ferring Pharmaceuticals
Nocturia Due to Nocturnal Polyuria
09/24
09/24
NCT05517590: Intravenous Tranexamic Acid and Intramyometrial Desmopressin Effect on Blood Loss During Laparoscopic Myomectomy.

Completed
N/A
102
RoW
Tranexamic acid, Group I, Saline, Group II
Acibadem University
Leiomyoma, Uterine, Intraoperative Blood Loss
04/24
04/24
NCT06772584: Ginko Biloba Versus Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis

Completed
N/A
90
RoW
Desmopressin Acetate 0.2 mg Tablets, Ginkgobiloba
Menoufia University
Enuresis, Nocturnal
07/24
12/24
NCT06285006: Desmopressin Monotherapy for Monosymptomatic Nocturnal Enuresis

Recruiting
N/A
50
RoW
Desmopressin
Al-Azhar University
Nocturnal Enuresis
05/24
05/24
NCT06771128: Ginkgo Biloba Vs Desmopressin in Treatment of Children with Monosymptomatic Nocturnal Enuresis

Recruiting
N/A
90
RoW
Ginkgo Biloba oral tablet, Desmopressin Acetate 0.2 mg Tablets
Menoufia University
Nocturnal Enuresis in Children, Desmopressin, Monosymptomatic Nocturnal Enuresis
05/25
07/25
NCT06883851: Effectiveness of Pelvic Floor Muscle Rehabilitation Combined With Desmopressin in Children With Primary Monosymptomatic Nocturnal Enuresis

Recruiting
N/A
40
RoW
Structured pelvic floor rehabilitation
Bahçeşehir University, Private Selcuk Sılay Pediatric Urology Clinic, Medipol Acıbadem Regional Hospital
Primary Nocturnal Enuresis, Nocturnal Enuresis in Children
03/27
08/27
GIDEMHA, NCT05628558: Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia A

Recruiting
N/A
800
Europe
Desmopressin, DDAVP
Groupe Maladies hémorragiques de Bretagne
Hemophilia A, Mild, Desmopressin, Factor VIII
12/22
04/23
NL72701.091.20, NCT05307042: Decline in Renal Concentration Ability in Lithium Treated Patients

Not yet recruiting
N/A
51
Europe
Deamino Arginine Vasopressin (dDAVP)
Radboud University Medical Center
Lithium Toxicities, Bipolar Disorder, Concentration Ability Impaired, Nephrogenic Diabetes Insipidus, Lithium - Induced Nephropathy
12/22
12/22
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
desmopressin / Generic mfg.
ChiCTR-IPR-15007055: The relationship between treatment for persistent nocturia in men following transurethral prostate surgery by Desmopressin Acetate Sublingual Wafer Oral Disintegration Formulation (Minirin Melt? 60 μg) and improvement of sleep quality

Recruiting
4
120
 
Minirin Melt versus placebo, 60mcg before bed, 4 weeks, respectively
The Chinese University of Hong Kong; Level of the institution：, The Chinese University of Hong Kong
Noctura
 
 
2011-004560-29: Desmopressin melt therapy in nocturnal polyuria patients: pharmacodynamic study Desmopressine Melt therapie bij patiënten met nachtelijke polyurie: farmacodynamische studie

Ongoing
4
50
Europe
Desmopressin, Oral lyophilisate, Minirin Melt 60 µg lyophilisaat voor oraal gebruik
Ghent University Hospital, Ghent University Hospital
Noctural polyuria, Noctural polyuria Nachtelijke polyurie, Body processes [G] - Physiological processes [G07]
 
 
2012-001809-24: A diminished concentrating ability of the kidneys due to lithium prescription: how many and whom is affected?

Ongoing
4
100
Europe
Desmopressine nasal spray 10 mg/ml, flacon 60 doses, SUB21605, Nasal spray, solution, Desmopressine nasal spray 10 mg/ml, flacon 60 doses
Radboud University Nijmegen Medical Centre, Radboud University Nijmegen Medical Centre
lithium-induced urinary concentrating defects (nephrogenic diabetes insipidus), excessive urine production due to a diminished urinary concentrating ability of the kidneys, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
2009-017060-17: STIMULATE study: Statins influence on Minrin upregulation of von Willebrand factor and factor VIII

Ongoing
4
20
Europe
simvastatin, Desmopressine, simvastatine, Minrin, simvastatine, Minrin
Academic Medical Center
Type 1 von Willebrand disease and mild hemophilia A
 
 
2014-005435-14: Combination treatment with DDAVP and factor VIII clotting factor concentrates in patients with mild haemophilia A. Combinatiebehandeling van DDAVP en factor VIII-concentraten in patiënten met milde hemofilie A.

Ongoing
4
60
Europe
Solution for injection/infusion, Powder and solvent for solution for injection, Minrin, Octostim, Advate, Kogenate Bayer, Helixate NexGen, ReFacto AF, Aafact, Octanate, NovoEight
Erasmus University Medical Center, ZonMw, Ferring BV, Erasmus University Medical Centre
Mild hemophilia A patients with a FVIII plasma levels above 0.05 IU/mL. Milde hemofilie A-patiënten, A clotting disorder in which clotting factor VIII is deficient, which can cause bleeding. In this study we will look at patients with the mild form. Een stollingsstoornis waarin het gehalte van stollingsfactor VIII is verlaagd. Hierdoor kunnen bloedingen veroorzaakt worden. In deze studie kijken we naar patiënten met een milde vorm., Diseases [C] - Blood and lymphatic diseases [C15]
 
 
2016-001875-57: Desmopressin and FVIII concentrate combination treatment in non-severe hemophilia A patients undergoing minor interventions Desmopressine en FVIII-concentraat combinatiebehandeling in niet-ernstige hemofilie A-patiënten die een kleine ingreep ondergaan

Ongoing
4
70
Europe
Solution for injection/infusion, Solution for injection, Minrin, Octostim
Erasmus University Medical Center Rotterdam, Erasmus University Medical Center Rotterdam, Innovatiefonds zorgverzekeraars
Hemophilia A Hemofilie A, Hemophilia A, a bleeding disorder caused by clotting fcator VIII deficiency, Diseases [C] - Blood and lymphatic diseases [C15]
 
 
PTNS, NCT04545931: Posterior Tibial Nerve Stimulation Vs Desmopressin In Children With Primary Monosymptomatic Nocturnal Enuresis

Recruiting
4
80
RoW
Posterior tibial nerve stimulation, Urgent PC, Desmopressin Acetate
Cairo University
Primary Monosymptomatic Nocturnal Enuresis
11/20
12/20
DRYCHILD, NCT03389412 / 2017-002169-23: The Effect of Selecting Treatment With Desmopressin or Alarm to Children With Enuresis Based on Home Recordings.

Completed
4
324
Europe, RoW
Desmopressin, Minirin, melt, Conditional alarm
University of Aarhus, University Ghent, First Affiliated Hospital of Zhengzhou University, China, University Clinical Centre in Gdansk, Poland
Enuresis, Nocturnal
01/23
01/23
NCT04420585: Desmopressin for Bedwetting in Children With SCD

Terminated
4
8
US
Desmopressin, DDAVP
Montefiore Medical Center
Nocturnal Enuresis, Anemia, Sickle Cell
06/23
06/23
NCT05945420: Adding Desmopressin to Tamsulosin for Treatment of BPH

Recruiting
4
160
RoW
Desmopressin Acetate, Placebo
Mansoura University
Nocturnal Polyurea in Patients With BPH
01/24
02/24
NCT06255366: Analysis of the Clinical Efficacy of Intravenous Application of Hemostatic Drugs in Improving the Clarity of Vision Under Endoscope, Perioperative Bleeding Volume and Anti-inflammatory Effect of Spinal Endoscopic Lumbar Fusion

Not yet recruiting
4
126
NA
Caroxime sodium sulfonate, Desmopressin, 0.9% Sodium Chloride Injection
Chengdu University of Traditional Chinese Medicine
Lumbar Spondylolisthesis, Arthrosis; Spine
12/24
06/25
NCT06622187: Use of Desmopressin Prior to Graft Kidney Biopsy in Patients with High Risk of Bleeding

Enrolling by invitation
4
96
RoW
Desmopressin (DDAVP), Sodium Chloride
Hospital de Clinicas de Porto Alegre
Bleeding, Transplant, Kidney, Desmopressin, Kidney Biopsy
06/26
06/26
2004-001735-37: AN OPEN LABEL STUDY OF ORAL DESMOPRESSIN IN CHILDREN AGED 5 TO 15 YEARS WITH PRIMARY NOCTURAL ENURESIS

Ongoing
3
110
Europe
MINIRIN, Tablet, MINIRIN
FERRING ARZNEIMITTEL Ges.m.b.h. CEE AUSTRIA
Primary noctural enuresis
 
 
2009-017265-33: Invloed van voeding op farmacokinetiek en -dynamiek van desmopressine tablet in vergelijking met desmopressine MELT-vorm

Ongoing
3
24
Europe
Desmopressine MELT, Desmopressine tablet, Oral lyophilisate, Tablet, Minrin MELT, Desmopressine Ferring
University Hospital Ghent
Kinderen met Monosymptomatische Enuresis Nocturna en nachtelijke polyurie
 
 
2005-005199-33: EFFICACY OF DESMOPRESSINA IN PATIENT WITH ACTIVE BLEEDING AFTER HEART SURGERY.

Ongoing
3
108
Europe
EMOSINT INIETT.10F 20 MCG/ML, EMOSINT INIETT.10F 20 MCG/ML
OSPEDALE S. RAFFAELE
HIGH BLEEDING AFTER HEART SURGERY
 
 
2021-006647-99: Efficacy of Desmopressin in safaty outcomes post kindey biopsy

Not yet recruiting
3
424
Europe
Infusion, Minirin (4 mcg/ml)
Medical University of Bialystok, Agencja Badań Medycznych
Rare and ultra-rare glomerulonephritis, Rare and ultra-rare glomerulonephritis, Not possible to specify
 
 
BRACKETS, NCT06337838: Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery () Pilot Trial

Not yet recruiting
3
100
NA
Desmopressin Injectable Solution, DDAVP, Tranexamic Acid Injectable Product, Cyklokapron, Placebo
Population Health Research Institute
Chronic Kidney Diseases, Acute Kidney Injury, Bleeding, Surgery
01/26
04/26
DASSOH, NCT06020495: Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia

Recruiting
3
260
Europe
DDAVP, Standard hyponatremia treatment
Assistance Publique - Hôpitaux de Paris
Hyponatremia
09/26
11/26
STOP-BLEED, NCT05467033: Safety Outcomes Post Kidney Biopsy - Randomized Clinical Evaluation of Efficacy of Desmopressin

Recruiting
3
424
Europe
Desmopressin, Minirin, intravenous infusion NaCl, 0,9% NaCl
Medical University of Bialystok
Kidney Biopsy
08/26
08/26
ACTRN12609000080224: Desmopressin for the Treatment of Orthostatic Hypotension and Excessive Nighttime Urination in Parkinson’s Disease

Recruiting
2
20
 
John O'Sullivan, Royal Brisbane & Women's Hospital
Nocturia, Parkinson's Disease, Orthostatic Hypotension
 
 
2005-003488-22: Regulation des Antidiuretisches Hormons (ADH) und der antidiuretischen Wirkung unter Glucocorticoid - Therapie

Ongoing
2
12
Europe
Decortin H 10 mg, Decortin H 20 mg, Desmopressinacetat, Decortin H 10 mg, Decortin H 20 mg, Minirin parenteral, Decortin H 10 mg, Decortin H 20 mg, Minirin parenteral
Charité CBF, Endokrinologie
Es geht um keine therapeutische Fragestellung. In dem geplanten Versuch mit gesunden Probanden soll der Mechanismus der Wasser Resorption in der Niere trotz supprimiertem ADH nach Glukokortikoid Behandlung untersucht werden.
 
 
2008-002636-15: Study on the treatment of therapy-resistant enuresis with desmopressin and reboxetine; a randomised, placebo-controlled, double-blinded, cross-over study

Ongoing
2
21
Europe
Edronax, Nocutil, Edronax, Nocutil
Uppsala University Children´s Hospital
Nocturnal enuresis (bedwetting)
 
 
2016-001126-33: A randomised controlled trial to evaluate the feasibility of administering a drug called desmopressin to Intensive Care patients prior to procedures or radiological interventions, for prophylaxis against bleeding.

Ongoing
2
40
Europe
OCTIM Injection, Solution for injection/infusion, OCTIM Injection
NHS Blood and Transplant, NHS Blood and Transplant
Thrombocytopenic patients (platelet count less than or equal to 100x109/L) in Intensive Care and due to undergo an interventional procedure., Patients with a low platelet count, in Intensive Care and due to undergo an interventional procedure., Diseases [C] - Blood and lymphatic diseases [C15]
 
 
NCT04586790: the Effect of Oral Vasopressors for Liberation From IV Vasopressors in Spinal Shock

Recruiting
2
90
RoW
Midodrine Oral Tablet, Minirin oral tablet, Nor-Adrenaline
Ahmed talaat ahmed aly
Spinal Shock
01/21
01/21
NCT06635629: Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome

Recruiting
2
140
US
Desmopressin, Dexamethasone
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Cushing Syndrome
10/28
01/29
ChiCTR-TRC-09000690: A Randomized, Double-blind, Placebo-controlled Study on Treatment of Nocturia with Desmopressin in Women

Completed
N/A
100
 
MINIRIN 0.2 mg tablets containing desmopressin acetate 0.2 mg and excipients q.s. (oral; 1 dose per night for 3 weeks) Patients will experience 1-week screening period and 3-week double-blind period ;Placebo (oral; 1 dose per night for 3 weeks)
N.A.; Level of the institution：, Department of Obstetrics & Gynaecology
Nocturia
 
 
ChiCTR1900022678: Desmopressin acetate decreases blood loss in patients with massive hemorrhage undergoing gastrointestinal surgery

Completed
N/A
150
 
desmopressin 0.3 ug/kg,30 min, once a day after the surgery. ;intravenously administered with 50 ml saline for 30 min once a day.
he Sixth Affiliated Hospital of Sun Yat-Sen University; the Sixth Affiliated Hospital of Sun Yat-Sen University, hybio pharmcceutical Co.Ltd
critical care ill
 
 
NCT06185361: Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.

Active, not recruiting
N/A
60
RoW
Fluoxetine 20 MG, Desmopressin
Fayoum University Hospital
Nocturnal Enuresis, Enuresis, Enuresis, Nocturnal
03/24
03/24
GIDEHAC, NCT06020456: Genetic Factors of the Desmopressin Response in Carriers of Hemophilia A

Completed
N/A
361
Europe
Desmopressin
Groupe Maladies hémorragiques de Bretagne
Carrier of Hemophilia A, Desmopressin, Factor VIII Deficiency
01/23
04/23
NCT05507476: Nasal Desmopressin Versus Topical Epinephrine in Endonasal Dacryocystorhinostomy

Completed
N/A
52
RoW
Desmopressin Acetate Nasal, 10 μg/0.1 ml per spray, Minirin 10 μg/0.1 ml per spray, Epinephrine topical 1:100,000 Nasal Packs, Adrenaline 1 mg / 1ml
Zagazig University
Anesthesia
06/23
06/23
NCT05617664: Mirabegron 25 mg for Treatment of Primary Nocturnal Enuresis

Recruiting
N/A
150
RoW
desmopressin 120 mcg oral tablets, Mirabegron 25 MG Oral Tablet, Extended Release, behavioral therapy alone
Benha University
Nocturnal Enuresis
09/23
10/23
NCT05399173: Effect of Laser Acupuncture for Treating Monosymptomatic Nocturnal Enuresis in Adolescent Females

Recruiting
N/A
60
RoW
infrared (gallium aluminum arsenide laser), medical treatment(desmopressin acetate)
Cairo University
Non-Specific Urethritis
09/23
09/23
NOC01, NCT04329975: Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)

Completed
N/A
1087
Japan
Desmopressin, MINIRINMELT
Ferring Pharmaceuticals
Nocturia Due to Nocturnal Polyuria
09/24
09/24
NCT05517590: Intravenous Tranexamic Acid and Intramyometrial Desmopressin Effect on Blood Loss During Laparoscopic Myomectomy.

Completed
N/A
102
RoW
Tranexamic acid, Group I, Saline, Group II
Acibadem University
Leiomyoma, Uterine, Intraoperative Blood Loss
04/24
04/24
NCT06772584: Ginko Biloba Versus Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis

Completed
N/A
90
RoW
Desmopressin Acetate 0.2 mg Tablets, Ginkgobiloba
Menoufia University
Enuresis, Nocturnal
07/24
12/24
NCT06285006: Desmopressin Monotherapy for Monosymptomatic Nocturnal Enuresis

Recruiting
N/A
50
RoW
Desmopressin
Al-Azhar University
Nocturnal Enuresis
05/24
05/24
NCT06771128: Ginkgo Biloba Vs Desmopressin in Treatment of Children with Monosymptomatic Nocturnal Enuresis

Recruiting
N/A
90
RoW
Ginkgo Biloba oral tablet, Desmopressin Acetate 0.2 mg Tablets
Menoufia University
Nocturnal Enuresis in Children, Desmopressin, Monosymptomatic Nocturnal Enuresis
05/25
07/25
NCT06883851: Effectiveness of Pelvic Floor Muscle Rehabilitation Combined With Desmopressin in Children With Primary Monosymptomatic Nocturnal Enuresis

Recruiting
N/A
40
RoW
Structured pelvic floor rehabilitation
Bahçeşehir University, Private Selcuk Sılay Pediatric Urology Clinic, Medipol Acıbadem Regional Hospital
Primary Nocturnal Enuresis, Nocturnal Enuresis in Children
03/27
08/27
GIDEMHA, NCT05628558: Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia A

Recruiting
N/A
800
Europe
Desmopressin, DDAVP
Groupe Maladies hémorragiques de Bretagne
Hemophilia A, Mild, Desmopressin, Factor VIII
12/22
04/23
NL72701.091.20, NCT05307042: Decline in Renal Concentration Ability in Lithium Treated Patients

Not yet recruiting
N/A
51
Europe
Deamino Arginine Vasopressin (dDAVP)
Radboud University Medical Center
Lithium Toxicities, Bipolar Disorder, Concentration Ability Impaired, Nephrogenic Diabetes Insipidus, Lithium - Induced Nephropathy
12/22
12/22

Download Options